These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7006142)

  • 21. Treatment of claudication with dipyridamole and aspirin.
    Libretti A; Catalano M
    Monogr Atheroscler; 1986; 14():207-9. PubMed ID: 3526127
    [No Abstract]   [Full Text] [Related]  

  • 22. Aggrenox: a combination of antiplatelet drugs for stroke prevention.
    Med Lett Drugs Ther; 2000 Feb; 42(1071):11-2. PubMed ID: 10725967
    [No Abstract]   [Full Text] [Related]  

  • 23. [Platelet antiaggregants: review of the literature (author's transl)].
    Sternon J
    Rev Med Brux; 1981 May; 2(5):487-92. PubMed ID: 7020033
    [No Abstract]   [Full Text] [Related]  

  • 24. Dipyridamole and aspirin in arteriosclerosis obliterans of the lower limbs.
    Davì G; Pinto A; Palumbo MG; Gallo V; Mazza A; Strano A
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():271-5. PubMed ID: 3159212
    [No Abstract]   [Full Text] [Related]  

  • 25. [The antithrombotic effect of dipyridamole and acetylsalicylic acid. A prospective clinical examination].
    Harjola PT; Meurala H
    Med Welt; 1981 Jul; 32(30-31):1178. PubMed ID: 7024707
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug trials in prevention of occlusion of aorta--coronary artery vein grafts.
    Chesebro JH; Fuster V
    J Thorac Cardiovasc Surg; 1982 Jan; 83(1):90-3. PubMed ID: 7033674
    [No Abstract]   [Full Text] [Related]  

  • 27. [Combination of acetylsalicylic acid with dipyridamole is better than acetylsalicylic acid monotherapy].
    Schindler B
    Med Monatsschr Pharm; 2006 Nov; 29(11):421-3. PubMed ID: 17131692
    [No Abstract]   [Full Text] [Related]  

  • 28. Prevalence of platelet nonresponsiveness to aspirin in patients treated for secondary stroke prophylaxis and in patients with recurrent ischemic events.
    Gengo FM; Rainka M; Robson M; Gengo MF; Forrest A; Hourihane M; Bates V
    J Clin Pharmacol; 2008 Mar; 48(3):335-43. PubMed ID: 18223144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trial of low doses of aspirin as prophylaxis in sickle cell disease.
    Greenberg J; Ohene-Frempong K; Halus J; Way C; Schwartz E
    J Pediatr; 1983 May; 102(5):781-4. PubMed ID: 6842340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombotic thrombocytopenic purpura successfully treated with a combination of dipyridamole and aspirin.
    Marmont AM; Damasio E; Rossi E; Spriano M
    Haematologica; 1980 Apr; 65(2):222-31. PubMed ID: 6769763
    [No Abstract]   [Full Text] [Related]  

  • 31. [For which patient ASS, clopidogrel or dipyridamole? (interview by Dr. Med. Dirk Einecke)].
    Diener HC
    MMW Fortschr Med; 2004 Jun; 146(24):50. PubMed ID: 15366496
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical trials of new therapeutic pharmacology for sickle cell disease].
    Brugnara C; de Franceschi L
    Sante; 2006; 16(4):263-8. PubMed ID: 17446160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The approach to optimizing stroke care.
    Panagos PD
    Am J Emerg Med; 2008 Sep; 26(7):808-16. PubMed ID: 18774049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trial of platelet-inhibiting drug in scleroderma. Double-blind study with dipyridamole and aspirin.
    Beckett VL; Conn DL; Fuster V; Osmundson PJ; Strong CG; Chao EY; Chesebro JH; O'Fallon WM
    Arthritis Rheum; 1984 Oct; 27(10):1137-43. PubMed ID: 6386002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [anti-platelet therapy or anti-coagulants as prevention in transient ischemic attacks and reversible ischemic stroke].
    Brechter C; Bäcklund H; Krook H; Müller R; Nitelius E; Olsson JE; Olsson O; Thornberg A
    Lakartidningen; 1980 Dec; 77(52):4947-56. PubMed ID: 7010029
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevention of postoperative deep vein thrombosis with dipyridamole and aspirin.
    Renney JT; O'Sullivan EF; Burke PF
    Br Med J; 1976 Apr; 1(6016):992-4. PubMed ID: 773495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination antiplatelet agents for secondary prevention of ischemic stroke.
    Vande Griend JP; Saseen JJ
    Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secondary prevention of stroke: does dipyridamole add to aspirin?
    Lowenthal A; Buyse M
    Acta Neurol Belg; 1994; 94(1):24-34. PubMed ID: 8140884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
    Hankey GJ
    Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.